P

A

PASA , Ambra

Last name: PASA

First name: Ambra

2015 (v1)

Publication

Metadata-only

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation

Cenderello, Giovanni Artioli, Stefania VISCOLI, CLAUDIO

Objectives: Chronic hepatitis C virus (HCV) is a leading cause of hospitalization and death in populations coinfected with human immunodeficiency virus (HIV). Sofosbuvir (SOF) is a pan-genotypic drug that should be combined with other agents as an oral treatment for HCV. We performed a 5-year horizon budget impact analysis of SOF-based regimens...

Uploaded on: April 14, 2023